Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prekindergarten and Kindergarten Predictors of Reading Comprehension in Monolingual English and Spanish-English Bilingual Sixth Graders.

Journal of speech, language, and hearing research : JSLHR·2026
Same author

Operationalizing AD Biomarker Return of Research Results: Methods from the KU ADRC.

Biopreservation and biobanking·2026
Same author

ELSO-score: A practical pre-ECMO risk model for predicting in-hospital mortality in patients receiving VA-ECMO.

International journal of cardiology·2026
Same author

Remote digital intervention targeting heart failure medical therapy: a randomized controlled trial.

Lancet regional health. Americas·2026
Same author

Aortic Root Thrombosis in LVAD Patients: An Underrecognized Problem With Evolving Management.

JACC. Case reports·2026
Same author

Two-Year Results of PROACTIVE-HF Trial Stratified by Left Ventricular Ejection Fraction.

Journal of cardiac failure·2026

Related Experiment Video

Updated: Jun 28, 2026

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
09:12

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

9.5K

Evaluating Heart Transplant Outcomes Using the SherpaPak Heart Storage System.

Spencer Finkbiner1, Tarun Dalia2, Joseph Mancuso3

  • 1From The University of Kansas School of Medicine, Kansas City, Kansas.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|April 8, 2025
PubMed
Summary

The SherpaPak Cardiac Transport System (SCTS) offers comparable heart transplant outcomes to traditional cold storage despite longer ischemic times. This hypothermic device ensures optimal donor heart transport, showing no significant differences in graft dysfunction or mortality.

Keywords:
SherpaPakcardiac allograft vasculopathyheart transplantmortalityprimary graft dysfunction

More Related Videos

Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
08:21

Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography

Published on: October 11, 2022

2.0K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

597

Related Experiment Videos

Last Updated: Jun 28, 2026

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation
09:12

A Pre-Clinical Porcine Model of Orthotopic Heart Transplantation

Published on: April 27, 2019

9.5K
Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography
08:21

Functional Assessment of the Donor Heart During Ex Situ Perfusion: Insights from Pressure-Volume Loops and Surface Echocardiography

Published on: October 11, 2022

2.0K
Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
08:49

Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems

Published on: August 2, 2024

597

Area of Science:

  • Cardiology
  • Transplantation Surgery
  • Medical Devices

Background:

  • Donor heart transport is critical for transplant success.
  • Hypothermic preservation aims to maintain organ viability.
  • The SherpaPak Cardiac Transport System (SCTS) is a newer device for this purpose.

Purpose of the Study:

  • To compare post-transplant outcomes between the SCTS and traditional cold storage (TCS) methods.
  • To evaluate the efficacy of SCTS in maintaining donor heart viability during transport.
  • To assess the impact of transport method on primary graft dysfunction, length of stay, and mortality.

Main Methods:

  • Retrospective analysis of 120 heart transplant patients (60 SCTS, 60 TCS) at KUMC (June 2020-June 2023).
  • Comparison of baseline characteristics, ischemic times, and post-transplant outcomes including PGD, LOS, mortality, and CAV.
  • Multivariate analysis to control for potential confounding factors.

Main Results:

  • The SCTS group experienced significantly longer ischemic times (204 min) compared to TCS (177 min; p=0.008).
  • No statistically significant differences were observed in primary graft dysfunction (PGD), length of stay (LOS), 1-year all-cause mortality, or 1-year cardiac allograft vasculopathy (CAV) between the groups.
  • Multivariate analysis confirmed no significant difference in PGD or LOS between SCTS and TCS.

Conclusions:

  • The SCTS is a viable alternative to traditional cold storage for heart transport.
  • Despite longer ischemic times associated with SCTS, patient outcomes post-heart transplant remain comparable.
  • This suggests SCTS effectively preserves donor hearts for transplantation.